♟️ Friday 22 May 2026 Fri, 22 May 2026

South Port New Zealand is navigating a significant leadership transition with CEO Nigel Gear stepping down after 8.5 years, replaced by port veteran Derek Nind, while Chair Philip Cory-Wright plans retirement. The company reports strong trading momentum, aiming for a record full year despite geopolitical uncertainties.

Vmoto Limited disclosed it held only one formal board meeting in FY25, relying heavily on circular resolutions, and outlined plans to increase meeting frequency in 2026. The company clarified its trade insurance arrangements and affirmed director independence amid ASX queries.

Finico Pty Ltd will not extend its unconditional cash offer for DTI Group shares, set to close on 29 May 2026, signaling a major governance shake-up and potential delisting.

TrivarX has contracted Beyond Drug Development to drive its Stabl-Im MRI imaging platform into Phase 1 trials, aiming to start safety testing in healthy volunteers by late 2026.

Godolphin Resources is spinning out its Narraburra Rare Earths Project into a new ASX-listed entity, Matrix Critical Minerals, with MST Financial appointed to spearhead the IPO expected in the second half of 2026.

Arafura Rare Earths launches a two-tranche A$350 million placement and a A$25 million share purchase plan, closing the equity funding gap for its Nolans Rare Earths Project ahead of construction.

Appen Limited's FY25 results reveal solid revenue growth driven by generative AI projects and a standout performance from its China segment. The company sets FY26 revenue guidance of $270-300 million, underpinned by operational efficiencies and expanding AI data services.

White Energy has inked a non-binding term sheet to acquire coal assets in Alabama and Queensland, backed by a $15 million capital raise and planned board reshuffle.

PMET Resources has kicked off a substantial 45,000-meter drilling program at its flagship Shaakichiuwaanaan Property in Quebec, aiming to bolster lithium, caesium, and tantalum resource development ahead of updated economic studies.

Oceania Healthcare Limited has delivered a standout FY26 with 16% higher sales, 20% EBITDA growth, and a 19% reduction in net debt, setting the stage for positive cash flow in FY27 despite no dividend declared this year.